Malabar Remedies Ltd
NSE: MALABARREMBSE: 540987Pharma Formulations
₹3,154.80
▲ 59.35 (+1.92%)
Key ratios
- Market cap
- ₹1,91,181 Cr
- Enterprise value
- ₹1,92,255 Cr
- 52-week range
- ₹1,906.15 – ₹3,331.55
- Day range
- ₹3,027.00 – ₹3,171.15
- P/E
- 40.79
- P/B
- 9.72
- EPS (TTM)
- ₹77.34
- Book value
- ₹324.61
- Dividend yield
- 1.15%
- ROE
- 24.07%
- ROCE
- 26.28%
- Debt / equity
- 0.31
- Interest cover
- 11.19x
- Current ratio
- 2.59
- Shares outstanding
- 60.60 Cr
- Face value
- ₹10.00
GroWiser rating
- Ownership5/5
- Valuation1/5
- Efficiency4/5
- Financials4/5
Scores (0–5) are calculated from published ratios using fixed thresholds. They describe the numbers and are not a recommendation to buy, sell or hold.
Strengths & limitations
Strengths
- Return on equity of 24.07% in the latest year.
- Profit has grown at 15.05% CAGR over 5 years.
- Interest is covered 11.19 times by operating profit.
Limitations
- Stock trades at 9.72 times its book value.
Generated automatically from the latest ratios using rule thresholds.
Growth (CAGR)
| 1Y | 3Y | 5Y | |
|---|---|---|---|
| Sales growth | +7.30% | +14.79% | +14.74% |
| Profit growth | +40.58% | +17.16% | +15.05% |
Compound annual growth based on annual results.
Ownership & margins
- Promoters
- 57.34%
- Pledged (promoter)
- 0.00%
- Operating margin
- 19.59%
- Net margin
- 12.45%
Peer comparison
| Company | Price | Market cap | P/E | ROE |
|---|---|---|---|---|
| Malabar Remedies | ₹3,154.80 | ₹1,91,181 Cr | 40.79 | 24.07% |
| Chambal Biotech | ₹603.25 | ₹1,50,209 Cr | 24.79 | 26.53% |
| Godavari Lifesciences | ₹883.50 | ₹28,007 Cr | 25.90 | 24.75% |
| Himgiri Pharma | ₹2,019.55 | ₹22,013 Cr | 28.36 | 15.75% |
About Malabar Remedies
Malabar Remedies Ltd is a fictitious company generated for demonstration. Its financial figures are sample data and do not describe any real business.
Frequently asked questions
What is the share price of Malabar Remedies?
The share price of Malabar Remedies was ₹3,154.80 as of 12 Nov 2026 (prices are delayed by 15 minutes).
What is the market cap of Malabar Remedies?
The market capitalisation of Malabar Remedies is ₹1,91,181 crore.
What is the P/E ratio of Malabar Remedies?
Malabar Remedies trades at a P/E of 40.79 based on trailing twelve-month EPS of ₹77.34.
Is Malabar Remedies debt free?
Malabar Remedies has a debt-to-equity ratio of 0.31.
What is the ROE of Malabar Remedies?
Malabar Remedies reported a return on equity of 24.07% and a return on capital employed of 26.28% in its latest financial year.
What is the promoter holding in Malabar Remedies?
Promoters hold 57.34% of Malabar Remedies; 0.00% of shares are pledged.